[DPHARMA] QoQ TTM Result on 30-Sep-2019 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
29-Nov-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Sep-2019 [#3]
Profit Trend
QoQ- 4.68%
YoY- 27.24%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 582,654 584,789 576,462 554,341 537,324 515,849 498,722 10.93%
PBT 70,825 69,750 70,809 74,528 70,598 65,197 59,666 12.12%
Tax -15,643 -15,381 -15,536 -16,919 -15,562 -13,738 -12,025 19.18%
NP 55,182 54,369 55,273 57,609 55,036 51,459 47,641 10.30%
-
NP to SH 55,182 54,369 55,273 57,609 55,036 51,459 47,776 10.09%
-
Tax Rate 22.09% 22.05% 21.94% 22.70% 22.04% 21.07% 20.15% -
Total Cost 527,472 530,420 521,189 496,732 482,288 464,390 451,081 11.00%
-
Net Worth 581,725 540,662 525,364 505,919 503,029 496,410 483,173 13.18%
Dividend
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Div 37,536 40,733 40,733 33,094 33,094 30,674 30,674 14.42%
Div Payout % 68.02% 74.92% 73.69% 57.45% 60.13% 59.61% 64.21% -
Equity
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Net Worth 581,725 540,662 525,364 505,919 503,029 496,410 483,173 13.18%
NOSH 684,383 684,383 684,383 680,106 661,881 661,881 661,881 2.25%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 9.47% 9.30% 9.59% 10.39% 10.24% 9.98% 9.55% -
ROE 9.49% 10.06% 10.52% 11.39% 10.94% 10.37% 9.89% -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 85.14 85.45 84.49 82.18 81.18 77.94 75.35 8.49%
EPS 8.06 7.94 8.10 8.54 8.32 7.77 7.22 7.62%
DPS 5.50 5.95 5.97 5.00 5.00 4.63 4.63 12.17%
NAPS 0.85 0.79 0.77 0.75 0.76 0.75 0.73 10.68%
Adjusted Per Share Value based on latest NOSH - 680,106
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 60.53 60.75 59.88 57.58 55.82 53.59 51.81 10.93%
EPS 5.73 5.65 5.74 5.98 5.72 5.35 4.96 10.10%
DPS 3.90 4.23 4.23 3.44 3.44 3.19 3.19 14.34%
NAPS 0.6043 0.5616 0.5457 0.5255 0.5225 0.5157 0.5019 13.18%
Price Multiplier on Financial Quarter End Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 -
Price 1.62 1.39 1.42 1.40 1.37 1.28 0.95 -
P/RPS 1.90 1.63 1.68 1.70 1.69 1.64 1.26 31.53%
P/EPS 20.09 17.50 17.53 16.39 16.48 16.46 13.16 32.61%
EY 4.98 5.72 5.70 6.10 6.07 6.07 7.60 -24.57%
DY 3.40 4.28 4.20 3.57 3.65 3.62 4.88 -21.42%
P/NAPS 1.91 1.76 1.84 1.87 1.80 1.71 1.30 29.26%
Price Multiplier on Announcement Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 13/08/20 18/05/20 13/02/20 29/11/19 30/08/19 21/05/19 18/02/19 -
Price 3.15 1.72 1.64 1.39 1.41 1.36 1.03 -
P/RPS 3.70 2.01 1.94 1.69 1.74 1.75 1.37 94.05%
P/EPS 39.07 21.65 20.24 16.28 16.96 17.49 14.27 95.83%
EY 2.56 4.62 4.94 6.14 5.90 5.72 7.01 -48.93%
DY 1.75 3.46 3.64 3.60 3.55 3.41 4.50 -46.75%
P/NAPS 3.71 2.18 2.13 1.85 1.86 1.81 1.41 90.70%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment